SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Temasek Holdings to invest Rs 945 crore in Glenmark Pharma

20 Apr 2015 Evaluate

Temasek Holdings, the investment arm of the Singapore government is all set to invest Rs 945 crore in Glenmark Pharmaceuticals. The move will help ease Glenmark’s debt burden of $420 million.

Temasek Holdings was considering investing in it through its wholly-owned subsidiary Aranda Investments (Mauritius), in equity shares to be issued by the company on a preferential basis.

Last year, Glenmark’s board had approved a proposal to merge Glenmark Pharmaceuticals’ subsidiaries - Glenmark Generics (GGL) and Glenmark Access (GAL) - with the parent company.

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×